GR3006343T3 - - Google Patents

Info

Publication number
GR3006343T3
GR3006343T3 GR920402701T GR920402701T GR3006343T3 GR 3006343 T3 GR3006343 T3 GR 3006343T3 GR 920402701 T GR920402701 T GR 920402701T GR 920402701 T GR920402701 T GR 920402701T GR 3006343 T3 GR3006343 T3 GR 3006343T3
Authority
GR
Greece
Application number
GR920402701T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3006343T3 publication Critical patent/GR3006343T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
GR920402701T 1987-10-09 1992-11-26 GR3006343T3 (cg-RX-API-DMAC10.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8723715A GB2210875B (en) 1987-10-09 1987-10-09 Aromatase inhibiting 4(5)-imidazoles

Publications (1)

Publication Number Publication Date
GR3006343T3 true GR3006343T3 (cg-RX-API-DMAC10.html) 1993-06-21

Family

ID=10625036

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920402701T GR3006343T3 (cg-RX-API-DMAC10.html) 1987-10-09 1992-11-26

Country Status (24)

Country Link
US (1) US5098923A (cg-RX-API-DMAC10.html)
EP (1) EP0311447B1 (cg-RX-API-DMAC10.html)
JP (1) JPH01132568A (cg-RX-API-DMAC10.html)
KR (1) KR890006593A (cg-RX-API-DMAC10.html)
CN (1) CN1036993C (cg-RX-API-DMAC10.html)
AU (1) AU615482B2 (cg-RX-API-DMAC10.html)
CA (1) CA1329616C (cg-RX-API-DMAC10.html)
DD (1) DD282912A5 (cg-RX-API-DMAC10.html)
DE (1) DE3874073T2 (cg-RX-API-DMAC10.html)
DK (1) DK550988A (cg-RX-API-DMAC10.html)
ES (1) ES2043839T3 (cg-RX-API-DMAC10.html)
FI (1) FI93105C (cg-RX-API-DMAC10.html)
GB (1) GB2210875B (cg-RX-API-DMAC10.html)
GR (1) GR3006343T3 (cg-RX-API-DMAC10.html)
HU (1) HU201024B (cg-RX-API-DMAC10.html)
IE (1) IE61180B1 (cg-RX-API-DMAC10.html)
IL (1) IL87969A (cg-RX-API-DMAC10.html)
LT (1) LT3658B (cg-RX-API-DMAC10.html)
NO (1) NO172048C (cg-RX-API-DMAC10.html)
NZ (1) NZ226483A (cg-RX-API-DMAC10.html)
PT (1) PT88717B (cg-RX-API-DMAC10.html)
RU (2) RU1819263C (cg-RX-API-DMAC10.html)
UA (1) UA13218A (cg-RX-API-DMAC10.html)
ZA (1) ZA887545B (cg-RX-API-DMAC10.html)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
GB8818561D0 (en) * 1988-08-04 1988-09-07 Ici Plc Diphenylethane derivatives
JPH032168A (ja) * 1989-03-30 1991-01-08 Farmos Yhtymae Oy アロマターゼ阻害活性を有する新規な4(5)―イミダゾール
US5439928A (en) * 1989-03-30 1995-08-08 Orion-Yhtyma Oy Aromatase inhibiting 4(5)-imidazoles
GB2229719B (en) * 1989-03-30 1992-04-29 Farmos Oy Novel aromatase inhibiting 4(5)-imidazoles
GB2248058B (en) 1990-09-21 1994-09-14 Orion Yhtymae Oy Aromatase inhibiting 4(5)-imidazoles
GB9125924D0 (en) 1991-06-18 1992-02-05 Orion Yhtymae Oy Stereoisomers of an imidazole derivative
US6262093B1 (en) 1995-04-12 2001-07-17 The Proctor & Gamble Company Methods of treating cancer with benzimidazoles
ZA962879B (en) * 1995-04-12 1997-03-17 Procter & Gamble A pharmaceutical composition for inhibiting the growth of viruses and cancers
US6479526B1 (en) 1995-04-12 2002-11-12 The Procter & Gamble Company Pharmaceutical composition for inhibiting the growth of viruses and cancers
US6265427B1 (en) 1995-06-07 2001-07-24 The Proctor & Gamble Company Pharmaceutical composition for the method of treating leukemia
AU1529997A (en) * 1996-01-16 1997-08-11 Warner-Lambert Company Substituted histidine inhibitors of protein farnesyltransferase
US5900429A (en) 1997-01-28 1999-05-04 The Procter & Gamble Company Method for inhibiting the growth of cancers
US6506783B1 (en) 1997-05-16 2003-01-14 The Procter & Gamble Company Cancer treatments and pharmaceutical compositions therefor
CN1275911A (zh) * 1997-08-15 2000-12-06 杜克大学 一种预防或治疗雌激素依赖性疾病及失调的方法
US6245789B1 (en) 1998-05-19 2001-06-12 The Procter & Gamble Company HIV and viral treatment
US6423734B1 (en) 1999-08-13 2002-07-23 The Procter & Gamble Company Method of preventing cancer
US6380232B1 (en) 2000-09-26 2002-04-30 The Procter & Gamble Company Benzimidazole urea derivatives, and pharmaceutical compositions and unit dosages thereof
US6407105B1 (en) 2000-09-26 2002-06-18 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6608096B1 (en) * 2000-09-26 2003-08-19 University Of Arizona Foundation Compounds and methods for use thereof in the treatment of cancer or viral infections
US6462062B1 (en) * 2000-09-26 2002-10-08 The Procter & Gamble Company Compounds and methods for use thereof in the treatment of cancer or viral infections
US6515074B2 (en) * 2001-01-22 2003-02-04 Delphi Technologies, Inc. Thermoplastic polymer alloy compositions and process for manufacture thereof
JP4324480B2 (ja) 2002-03-26 2009-09-02 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド グルココルチコイドミメティクス、その製法、医薬組成物、及び使用
EP1490317A1 (en) * 2002-03-26 2004-12-29 Boehringer Ingelheim Pharmaceuticals Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
US7074806B2 (en) 2002-06-06 2006-07-11 Boehringer Ingelheim Pharmaceuticals, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
EP1583745A1 (en) 2003-01-03 2005-10-12 Boehringer Ingelheim Pharmaceuticals Inc. 1-propanol and 1-propylamine derivatives and their use as glucocorticoid ligands
UY28526A1 (es) 2003-09-24 2005-04-29 Boehringer Ingelheim Pharma Miméticos de glucocorticoides, métodos de preparación composiciones farmacéuticas y usos de los mismos
US7795272B2 (en) 2004-03-13 2010-09-14 Boehringer Ingelheim Pharmaceutical, Inc. Glucocorticoid mimetics, methods of making them, pharmaceutical compositions and uses thereof
PE20060776A1 (es) 2004-12-27 2006-09-26 Boehringer Ingelheim Pharma Mimeticos de glucocorticoides, metodos para prepararlos y composiciones farmaceuticas
MX2009005264A (es) 2006-12-06 2009-05-28 Boehringer Ingelheim Int Mimeticos de glucocorticoides, metodos para su fabricacion, composiciones farmaceuticas y usos de los mismos.
EP2095819A1 (en) * 2008-02-28 2009-09-02 Maastricht University N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
DK2300472T3 (da) 2008-06-06 2012-04-10 Boehringer Ingelheim Int Glucocorticoidmimetika, fremgangsmåder til disses fremstilling, farmaceutiske sammensætninger samt anvendelser deraf

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2069481B (en) * 1980-02-13 1983-07-27 Farmos Oy Substituted imidazole derivatives
GB2092569B (en) * 1981-02-05 1984-09-19 Farmos Oy Substituted imidazole derivatives and their preparation and use
GB2096987B (en) * 1981-04-22 1984-04-04 Farmos Oy Substituted imidazole and imidazole derivatives and their preparation and use
GB2101114B (en) * 1981-07-10 1985-05-22 Farmos Group Ltd Substituted imidazole derivatives and their preparation and use
US4605661A (en) * 1984-06-18 1986-08-12 Eli Lilly And Company Aromastase inhibiting α,α-diarylimidazole-4(5)-propionitriles, α,α-diarylimidazole-4(5)-propionamides, and 4(5)-(2,2-diarylethyl)imidazoles
LU85747A1 (fr) * 1985-01-28 1986-08-04 Continental Pharma Derives d'imidazole leur preparation et utilisation ainsi que les compositions pharmaceutiques contenant des derives
GB2210875B (en) 1987-10-09 1991-05-29 Farmos Oy Aromatase inhibiting 4(5)-imidazoles
JPH032168A (ja) 1989-03-30 1991-01-08 Farmos Yhtymae Oy アロマターゼ阻害活性を有する新規な4(5)―イミダゾール

Also Published As

Publication number Publication date
NO884473L (no) 1989-04-10
HU201024B (en) 1990-09-28
IE883055L (en) 1989-04-09
GB2210875B (en) 1991-05-29
CA1329616C (en) 1994-05-17
KR890006593A (ko) 1989-06-14
GB8723715D0 (en) 1987-11-11
AU615482B2 (en) 1991-10-03
EP0311447A1 (en) 1989-04-12
JPH01132568A (ja) 1989-05-25
DK550988D0 (da) 1988-10-03
DD282912A5 (de) 1990-09-26
IL87969A0 (en) 1989-03-31
NO172048C (no) 1993-06-02
DE3874073T2 (de) 1993-01-21
IL87969A (en) 1993-04-04
IE61180B1 (en) 1994-10-05
ES2043839T3 (es) 1994-01-01
LT3658B (en) 1996-01-25
PT88717B (pt) 1992-12-31
FI93105C (fi) 1995-02-27
NO884473D0 (no) 1988-10-07
FI884497A0 (fi) 1988-09-30
HUT49582A (en) 1989-10-30
US5098923A (en) 1992-03-24
LTIP916A (en) 1995-03-27
RU2045519C1 (ru) 1995-10-10
RU1819263C (ru) 1993-05-30
DE3874073D1 (de) 1992-10-01
FI93105B (fi) 1994-11-15
AU2349088A (en) 1989-04-13
DK550988A (da) 1989-04-10
EP0311447B1 (en) 1992-08-26
FI884497A7 (fi) 1989-04-10
GB2210875A (en) 1989-06-21
NO172048B (no) 1993-02-22
ZA887545B (en) 1989-06-28
CN1036993C (zh) 1998-01-14
UA13218A (uk) 1997-02-28
CN1033995A (zh) 1989-07-19
NZ226483A (en) 1991-02-26

Similar Documents

Publication Publication Date Title
IN171582B (cg-RX-API-DMAC10.html)
FR2723216B1 (cg-RX-API-DMAC10.html)
IN168388B (cg-RX-API-DMAC10.html)
GR3003892T3 (cg-RX-API-DMAC10.html)
GR3003900T3 (cg-RX-API-DMAC10.html)
AU6000786A (cg-RX-API-DMAC10.html)
AU5597786A (cg-RX-API-DMAC10.html)
AU6354986A (cg-RX-API-DMAC10.html)
AU6743887A (cg-RX-API-DMAC10.html)
AU6818487A (cg-RX-API-DMAC10.html)
AU6234086A (cg-RX-API-DMAC10.html)
AU7016787A (cg-RX-API-DMAC10.html)
AU6030386A (cg-RX-API-DMAC10.html)
AU5537486A (cg-RX-API-DMAC10.html)
AU6268886A (cg-RX-API-DMAC10.html)
AU5857686A (cg-RX-API-DMAC10.html)
AU6245986A (cg-RX-API-DMAC10.html)
AU5648086A (cg-RX-API-DMAC10.html)
AU6757687A (cg-RX-API-DMAC10.html)
AU5977686A (cg-RX-API-DMAC10.html)
AU6085986A (cg-RX-API-DMAC10.html)
IN168963B (cg-RX-API-DMAC10.html)
IN169863B (cg-RX-API-DMAC10.html)
BG44629A1 (cg-RX-API-DMAC10.html)
BG44822A1 (cg-RX-API-DMAC10.html)